Journal of Urologic Oncology

Editorial

March 31, 2025

Editorial for JUO 2025 Vol. 23 No. 1 - Highlights of This Issue’s Papers and the JUO Editors’ Pick

Cheol Kwak

J Urol Oncol. 2025;23(1):1-3.

Invited Review

March 31, 2025

Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review

Gabriela M. Diaz, Peter S. Palencia, Michael S. Leapman

J Urol Oncol. 2025;23(1):4-13.

Precision oncology offers a transformative approach to managing localized prostate cancer (PCa) by tailoring interventions to the biological characteristics of the disease. This strategy addresses critical challenges such as overdiagnosis,...

Original Article

March 31, 2025

The Clinical Impact of Depression and Anxiety on Complications After Prostate Cancer Treatment: A Retrospective Cohort Study

Elliott J. Druten, Will P. Hoover, Jacob Bardell, et al.

J Urol Oncol. 2025;23(1):14-19.

Purpose: This large retrospective study aims to better understand the relationship of depression and anxiety with posttreatment complications in prostate cancer patients, specifically erectile dysfunction (ED) and urinary incontinence. Materials and...

Original Article

March 31, 2025

A Urologist’s Perspective: Initial Experiences With SpaceOAR Hydrogel Insertion for Prostate Cancer Patients

Hyunho Han, Ik Jae Lee, Woong Sub Koom, et al.

J Urol Oncol. 2025;23(1):20-29.

Purpose: To evaluate the placement accuracy and learning curve of SpaceOAR hydrogel and gold fiducial marker insertion in Korean prostate cancer patients undergoing carbon ion radiotherapy (CIRT), performed by a...

Original Article

March 31, 2025

Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy

Hyun Jung Lee, Won Hoon Song, Seung Soo Lee, et al.

J Urol Oncol. 2025;23(1):30-37.

Purpose: The extent of seminal vesicle invasion (SVI) in prostate cancer can be classified into muscle layer invasion (SVI-muscle) and mucosal layer invasion (SVI-mucosa). This study aimed to evaluate the...

Invited Review

March 31, 2025

Selection of Optimal Neoadjuvant Therapy Before Cytoreductive Nephrectomy and Its Biomarker in Renal Cell Carcinoma

Renpei Kato

J Urol Oncol. 2025;23(1):38-46.

Cytoreductive nephrectomy (CN) has been a pivotal consideration in the treatment of metastatic renal cell carcinoma, with its role evolving significantly in the era of immuno-oncology (IO) therapies. This review...

Original Article

March 31, 2025

Predicting Oncological and Functional Outcomes by Nephrectomy Type for T1 Renal Tumors Using Machine Learning Models

Dongrul Shin, Maisy Song, Jungyo Suh, et al.

J Urol Oncol. 2025;23(1):47-53.

Purpose: Determining the optimal surgical approach for patients with T1 renal tumors requires balancing long-term oncological and renal functional outcomes. Using machine learning algorithms, we aimed to develop a model...

Original Article

March 31, 2025

Prognostic Implications of Serum Carbonic Anhydrase IX in Clear Cell Renal Cell Carcinoma

Mónica Sanz del Pozo, Cristina Plaza Alonso, Álvaro Linacero Gracia, et al.

J Urol Oncol. 2025;23(1):54-62.

Purpose: The present study aimed at determining the expression of carbonic anhydrase IX (CAIX) in tissue and serum of patients with clear cell renal cell carcinoma (ccRCC) and its relationship...

Invited Review

March 31, 2025

A Review of Emerging Neoadjuvant Intravesical Strategies to Enhance Systemic Immune Checkpoint Blockade in Patients With Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Through the Induction of Immunogenic Cell Death and Activation of Tertiary Lymphoid Structure formation

Hye Won Lee, Hyun Hwan Sung

J Urol Oncol. 2025;23(1):63-78.

Patients diagnosed with muscle-invasive bladder cancer (MIBC) frequently exhibit a high incidence of micrometastatic disease. The current standard of care for localized MIBC involves cisplatin-based neoadjuvant chemotherapy followed by radical...

Original Article

March 31, 2025

Impact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study

Jiwoong Yu, Wook Nam, Kyung Hwan Kim, et al.

J Urol Oncol. 2025;23(1):79-87.

Purpose: To evaluate whether extended pelvic lymph node dissection (PLND) improves survival outcomes compared with standard PLND in patients with bladder cancer (BCa) undergoing radical cystectomy (RC), and to assess...

Original Article

March 31, 2025

Gender and Menopause Impact on Recurrence and Cancer-Specific Mortality in Bladder Cancer After Radical Cystectomy: A Retrospective Cohort Study

Jee Soo Park, Won Sik Jang, Jieun Heo, et al.

J Urol Oncol. 2025;23(1):88-93.

Purpose: Although bladder cancer occurs three to 4 times more frequently in men than in women, the relative number of deaths compared to incidence is higher in women, suggesting that...

Current Issue: Volume 23(1); Mar 2025

This archive contains links to the full-text of all issues.

Current issue

Volume 23(1); March

All issues

Vol. 23
2025

v.23(1) Mar 2025

Vol. 22
2024

v.22(1) Mar 2024

v.22(2) Jul 2024

v.22(3) Nov 2024

Vol. 21
2023

v.21(1) Mar 2023

v.21(2) Jul 2023

v.21(3) Nov 2023

The Korean Journal of Urological Oncology2003 (v1 n1) to 2022 (v22 n4)

Vol. 20
2022

v.20(1) Feb 2022

v.20(2) May 2022

v.20(3) Aug 2022

v.20(4) Nov 2022

Vol. 19
2021

v.19(1) Feb 2021

v.19(2) May 2021

v.19(3) Aug 2021

v.19(4) Nov 2021

Vol. 18
2020

v.18(1) Apr 2020

v.18(2) Aug 2020

v.18(3) Dec 2020

Vol. 17
2019

v.17(1) Apr 2019

v.17(2) Aug 2019

v.17(3) Dec 2019

Vol. 16
2018

v.16(1) Apr 2018

v.16(2) Aug 2018

v.16(3) Dec 2018

Vol. 15
2017

v.15(1) Apr 2017

v.15(2) Aug 2017

v.15(3) Dec 2017

Vol. 14
2016

v.14(1) Apr 2016

v.14(2) Aug 2016

v.14(3) Dec 2016

Vol. 13
2015

v.13(1) Apr 2015

v.13(2) Aug 2015

v.13(3) Dec 2015

Vol. 12
2014

v.12(1) Apr 2014

v.12(2) Aug 2014

v.12(3) Dec 2014

Vol. 11
2013

v.11(1) Apr 2013

v.11(2) Aug 2013

v.11(3) Dec 2013

Vol. 10
2012

v.10(1) Apr 2012

v.10(2) Aug 2012

v.10(3) Dec 2012

Vol. 9
2011

v.9(1) Apr 2011

v.9(2) Aug 2011

v.9(3) Dec 2011

Vol. 8
2010

v.8(1) Apr 2010

v.8(2) Aug 2010

v.8(3) Dec 2010

Vol. 7
2009

v.7(1) Apr 2009

v.7(2) Aug 2009

v.7(3) Dec 2009

Vol. 6
2008

v.6(1) Apr 2008

v.6(2) Aug 2008

v.6(3) Dec 2008

Vol. 5
2007

v.5(1) Apr 2007

v.5(2) Aug 2007

v.5(3) Dec 2007

Vol. 4
2006

v.4(1) Jun 2006

v.4(2) Dec 2006

Vol. 3
2005

v.3(1) Jun 2005

v.3(2) Dec 2005

Vol. 2
2004

v.2(1) Mar 2004

v.2(2) Jun 2004

v.2(3) Sep 2004

v.2(4) Dec 2004

Vol. 1
2003

v.1(1) Mar 2003

v.1(2) Jun 2003

v.1(3) Sep 2003

v.1(4) Dec 2003

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

7,511	Complex Epidemiology of Prostate Cancer in Asian Countries
5,561	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
5,091	Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
4,822	Current Update on Prostate Cancer Immunotherapy
4,142	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up

Cited By 12	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 11	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 5	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 5	Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By 4	A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening